Home › Compare › DTCFF vs VICI

DTCFF vs VICI: Dividend Comparison 2026

DTCFF yields 500.00% · VICI yields 6.57%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTCFF wins by $61398.54M in total portfolio value
10 years
DTCFF
DTCFF
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full DTCFF calculator →
VICI
VICI Properties Inc.
● Live price
6.57%
Share price
$27.12
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$988.8K
Annual income
$623,261.32
Full VICI calculator →

Portfolio growth — DTCFF vs VICI

📍 DTCFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTCFFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTCFF + VICI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DTCFF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTCFF
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
VICI
Annual income on $10K today (after 15% tax)
$558.67/yr
After 10yr DRIP, annual income (after tax)
$529,772.12/yr
At 15% tax rate, DTCFF beats the other by $37,453,511,966.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTCFF + VICI for your $10,000?

DTCFF: 50%VICI: 50%
100% VICI50/50100% DTCFF
Portfolio after 10yr
$30700.26M
Annual income
$22,032,100,888.51/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

DTCFF
No analyst data
Altman Z
-31.5
Piotroski
1/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+16.5% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTCFF buys
0
VICI buys
0
No recent congressional trades found for DTCFF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTCFFVICI
Forward yield500.00% ✓6.57%
Annual dividend / share$2.00 ✓$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3% ✓
Portfolio after 10y$61399.52M ✓$988.8K
Annual income after 10y$44,063,578,515.70 ✓$623,261.32
Total dividends collected$59892.67M ✓$948.4K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DTCFF vs VICI ($10,000, DRIP)

YearDTCFF PortfolioDTCFF Income/yrVICI PortfolioVICI Income/yrGap
1← crossover$60,700$50,000.00$11,368$948.43+$49.3K → DTCFF
2$348,594$283,644.86$13,339$1,493.16+$335.3K → DTCFF
3$1,895,372$1,522,376.89$16,326$2,426.21+$1.88M → DTCFF
4$9,763,990$7,735,942.00$21,123$4,112.15+$9.74M → DTCFF
5$47,691,977$37,244,507.54$29,379$7,368.23+$47.66M → DTCFF
6$221,049,019$170,018,603.23$44,804$14,191.64+$221.00M → DTCFF
7$972,993,924$736,471,474.07$76,658$29,972.12+$972.92M → DTCFF
8$4,070,762,075$3,029,658,575.98$150,894$71,015.81+$4070.61M → DTCFF
9$16,201,818,371$11,846,102,950.68$350,814$193,582.47+$16201.47M → DTCFF
10$61,399,524,173$44,063,578,515.70$988,809$623,261.32+$61398.54M → DTCFF

DTCFF vs VICI: Complete Analysis 2026

DTCFF — Stock

Defence Therapeutics Inc., a biotechnology company, engages in the research and development of biological/biosimilar therapeutic drugs for cancer and infectious diseases. Its proprietary platform is the ACCUMTM technology, which enables precision delivery of vaccine antigens or ADCs in their intact form to target cells. The company focuses on developing dendritic cell cancer vaccines; protein-based vaccine formulation against COVID and infectious diseases; and antibody drug conjugates (ADC) products targeting various cancers. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

Full DTCFF Calculator →

VICI — REIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this DTCFF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTCFF vs SCHDDTCFF vs JEPIDTCFF vs ODTCFF vs KODTCFF vs MAINDTCFF vs NNNDTCFF vs EPRTDTCFF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.